As of January 23, 2025, NuCana (NCNA) has a market cap of $4.357 million USD. According to our data, NuCana is ranked No.9076 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $4.36 M |
-6.72%
|
Dec 31, 2024 | $4.67 M |
-83.92%
|
Dec 29, 2023 | $29.05 M |
-55.15%
|
Dec 30, 2022 | $64.77 M |
-72.27%
|
Dec 31, 2021 | $0.23 B |
-46.99%
|
Dec 31, 2020 | $0.44 B |
-26.39%
|
Dec 31, 2019 | $0.60 B |
-57.93%
|
Dec 31, 2018 | $1.42 B |
43.42%
|
Dec 29, 2017 | $0.99 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Market Cap | = | NCNA Stock Price | * | NCNA Shares Outstanding |
= | $1.11 | * | 3.93 M | |
= | $4.36 M |